GS Is Up 70% in a Year. Now the Hard Part.

Hey there, bargain hunter. Goldman Sachs closed Wednesday around $1,060. The 52-week low was $705. That is a 50% move in twelve months, and from the April 2025 Liberation Day low the recovery is closer to 100%. At some point, a stock stops being a recovery play and starts being a momentum bet on sustained peak performance. GS crossed that line a few months ago. The question worth answering today is whether any margin of safety remains at current prices, or whether the market has already taken every dollar of good news off the table.

Scoreboard

Goldman reported Q2 2026 results on July 14. The numbers did not just beat consensus. They embarrassed it.

• Revenue: $20.34 billion vs. $16.40 billion expected. Beat of roughly 24%.
• Diluted EPS: $20.98 vs. consensus of $14.54. Beat of 44%.
• Net earnings: $6.63 billion, up 84% from $3.47 billion in Q2 2025.
• Return on equity: 23.5% annualized. ROTE of 25.5%.
• Global Banking and Markets revenue: $15.52 billion, up 53% year over year. A record.
• Equities revenue: $7.42 billion, up 72% year over year.
• Investment banking fees: $3.40 billion, up 55%, led by a 130% surge in equity underwriting.
• Asset and Wealth Management revenue: $4.60 billion, up 20%. Management fees hit a record $3.4 billion.
• Assets under supervision: $4.04 trillion, a record, up from $3.29 trillion a year ago.
• Efficiency ratio: 57.4% for the quarter.
• Quarterly dividend: Raised to $5.00, up 25% year over year.
• Buybacks: $4.00 billion repurchased in Q2 alone.
• Next earnings date: October 13, 2026.

To anchor those figures: Q2 EPS of $20.98 compares to $10.91 in Q2 2025. The trailing twelve-month EPS base now sits around $65.53, with revenue running at roughly $67.6 billion annualized. This is not a company that squeaked past a low bar. It obliterated a high one.

The Real Reason This Happened

When Liberation Day hit in April 2025, the market assumed Goldman would be collateral damage. Tariff-driven uncertainty was supposed to freeze M&A activity, kill the IPO window, and force hedge fund clients to shrink their books. The stock dropped alongside every other capital markets name. That fear was real. The assumption turned out to be wrong.

Here is what actually happened. The volatility created by tariff announcements and shifting trade policy did not destroy Goldman’s revenue. It turbocharged it. Derivatives volumes surged as institutional clients scrambled to hedge. Prime brokerage financing expanded. The equities desk, which earns fees on both sides of client repositioning, ran at a pace that will be difficult to sustain in calmer conditions.

On the deal side, corporate confidence recovered faster than anyone in April 2025 would have predicted. Large-cap M&A volumes surged 90% year to date through Q2, with Goldman leading $1.2 trillion in announced deal volumes and holding the top M&A advisor position globally. Investment banking fees of $3.40 billion were the highest quarterly figure the firm has reported since 2021. The IB backlog, which management disclosed had reached a five-year high, signals that the pipeline has not yet peaked.

Finviz noted Goldman surged nearly 5% on a single day in May after winning lead role on a high-profile IPO. That kind of event-driven premium is embedded in both the fee line and the stock multiple.

What the Business Actually Is

Goldman Sachs runs three segments. Two of them matter for this analysis.

Global Banking and Markets is the engine. It houses the equities and FICC trading desks, the investment banking franchise, and the firm’s lending book. In Q2 2026 it generated $15.52 billion in net revenues, up 53% year over year. Equities alone at $7.42 billion contributed more than a third of total firm revenue in a single quarter. That number, to be direct, will not repeat every quarter.

Asset and Wealth Management is the stabilizer, and increasingly the story for long-duration investors. This segment manages $4.04 trillion in client assets, up from $3.29 trillion a year ago. The Q2 quarter included $91 billion of long-term net inflows and $139 billion of liquidity product net inflows. Management fees, which are recurring and relatively predictable, hit a record $3.4 billion in the quarter. As the trading desk fluctuates, this fee base provides a floor that did not exist at meaningful scale a decade ago. Goldman expects full-year alternatives fundraising to exceed $125 billion, with incentive fees projected to rise materially in H2 2026.

Platform Solutions, the legacy consumer segment, generated $221 million in net revenues and a small pre-tax loss. It is a drag. Management knows it. Continued simplification here is the only incremental positive that remains in this segment.

The Macro Engines Running Under This

There are two forces propelling Goldman’s current cycle. Both are real. Both are finite.

The first is the AI infrastructure wave. The capital formation around AI, from hyperscaler buildouts to software acquisitions to data center financing, has created a sustained deal and issuance cycle. Goldman’s own management cited AI-driven capital formation and infrastructure buildout as fueling demand for advisory, financing, and risk management services across sectors. That cycle is multi-year, not multi-quarter, and Goldman sits at the center of it as one of the most consequential prime brokers for hedge fund AI-related flows.

The second engine is geopolitical volatility itself. Middle East conflict, tariff uncertainty, and unstable Fed expectations have kept hedging demand elevated and forced institutional clients to reposition capital frequently. That activity flows directly into Goldman’s equities and FICC desks. The counterintuitive reality: instability has been structurally good for Goldman’s revenue mix in 2025 and 2026.

The risk to both engines is symmetrical. A durable trade resolution, a ceasefire, or a decisive Fed pivot could reduce the hedging volume that has powered record equities revenues. Goldman’s own forward risk disclosures flag changes in international trade policies, new tariffs, continuation of the Middle East conflict, and securities market volatility as key uncertainties. The firm is telling you what it depends on.

Is It Cheap?

At roughly $1,060, GS trades at about 16x trailing twelve-month earnings of approximately $65.53 per share. The P/E is not alarming in isolation. What matters is whether those trailing earnings are repeatable.

Consensus Q3 2026 EPS sits around $16.90 on revenue of $17.86 billion, according to aggregated estimates. That is a meaningful step-down from Q2’s $20.98. The market is already pricing in some normalization. The debate is how much normalization is coming and how fast.

The bull argument for the multiple: the business has changed. Management fees from $4 trillion in AUS, recurring prime brokerage financing income, and more stable alternatives revenue now represent a larger share of earnings than they did five years ago. A higher structural multiple than Goldman has historically commanded may be warranted. Net margin of 29.6% versus 26.8% a year ago is the data point that supports this argument most clearly.

The bear argument is blunter: trailing earnings grew 35.9% in the last year while the five-year average shows earnings declining 2.7% per year. One of those numbers is a structural shift. The other is a cyclical surge. They cannot both be true at the same time, and the stock price is only cheap if you believe the former.

Analyst targets reflect this split. Wells Fargo is at $1,195. BofA raised its target to $1,150. UBS, reiterated Neutral, just lifted its target to $1,150 from $1,120. BMO Capital has moved to $1,190. JPMorgan raised its target to $900 from $826, notably below where the stock trades today. The consensus across roughly 25 analysts sits around $1,141. With the stock near $1,060, the implied upside to consensus is approximately 7.6%.

That is not a cheap stock. It is a fairly priced one, at best, if the cycle holds.

Bull / Base / Bear

Bull Case

The IB backlog converts. The five-year high in advisory mandates produces a strong H2 2026 fee quarter. Equities revenues normalize to $5.5 to $6 billion per quarter rather than collapsing. Full-year EPS runs north of $70. The AI infrastructure deal cycle extends well into 2027, keeps the fee pipeline full, and the AUS base crosses $4.5 trillion within four quarters. At 17x on $70 EPS, the stock is worth $1,190. Wells Fargo’s $1,195 target is the closest proxy for this scenario.

Base Case

Equities trading cools from record levels. Volatility subsides enough to reduce hedging volumes without triggering a full reversal. Investment banking fees hold in the $2.5 to $3 billion range per quarter rather than sustaining the Q2 peak. Asset and Wealth Management becomes the main earnings growth story. Full-year EPS lands around $62 to $65. The stock trades in a range between $1,000 and $1,150 as the market awaits confirmation that the earnings run rate is durable. Single-digit total return from current levels over the next 12 months.

Bear Case

A trade deal and a Middle East ceasefire arrive simultaneously. Hedge fund clients reduce prime brokerage leverage as volatility compresses. Equities revenue falls back toward $4 billion per quarter. M&A slows if financing costs stay elevated. Full-year EPS disappoints against a consensus that was calibrated to H1 strength. The stock re-rates toward 14x on lower earnings, implying a price in the $840 to $880 range. JPMorgan’s $900 target, sitting below the current price, already gestures in this direction.

Action Plan

There is no panic entry here. The Liberation Day low at roughly $511 was the gift. The 52-week low of $705 was still a reasonable entry. At $1,060, you are paying a fair price for a strong business in a favorable cycle, with limited room for error.

For long-term holders who bought below $800: hold. The compounding case through the AUS growth engine, rising management fees, and a structurally stronger balance sheet is intact. Trim a small position above $1,150 if Q3 equities revenues disappoint.

For new buyers: the risk/reward is not asymmetric in your favor at current prices. If you want exposure, scale in. A first tranche at current levels, a second tranche only if the stock pulls back toward $950 on any macro deterioration or Q3 earnings softness. Do not chase a stock that has already returned 70% in twelve months expecting the same in the next twelve.

Watch the $980 level. A close below it on volume would break the post-April 2025 recovery structure and warrant a reassessment. The post-earnings spike high of approximately $1,153, set on July 15, is near-term resistance.

Cheap Investor Scorecard

• Q3 equities revenue: Sustainable above $5.5B? Or was $7.42B a one-quarter anomaly? This is the most important number to watch on October 13.
• IB backlog conversion rate: Backlog at a five-year high means nothing if announced deals slip, re-trade, or get abandoned. Watch closed volumes, not pipeline.
• AUS net inflows: Q2 brought $91B in long-term inflows. If equity markets correct, fee-paying AUS can shrink faster than management fees suggest.
• Management fee growth rate: Record $3.4B in Q2. Can this grow 15% to 20% annually as alternatives fundraising scales past $125B for the year?
• FICC revenues: $4.59B in Q2, up 32% year over year. Any Fed pivot or rate stability could compress this line materially in H2.
• Platform Solutions trend: Still a pre-tax loss. Watch for any further rundown or strategic exit that removes the drag entirely.
• Prime brokerage leverage: If Goldman’s hedge fund clients reduce gross exposure, equities revenues suffer before any visible macro catalyst explains why.
• Book value per share: Grew to $367.67, up 2.8% year to date. The P/B multiple at roughly 2.9x reflects significant franchise premium above tangible book.
• Capital return sustainability: $5.36B returned in Q2. Buybacks only make sense below intrinsic value. At $1,060, management is buying back stock at nearly 3x book.
• Next earnings date: October 13, 2026. Before market open. Mark it.

Bottom Line

If Goldman can sustain full-year EPS north of $65 and the IB backlog converts cleanly in H2, the stock is reasonably priced here and could grind toward $1,150 over the next twelve months. That is a 8% to 9% return before dividends. Acceptable for a core financial holding, not compelling for a new position sized for outsized gains.

If equities revenues normalize toward $5 billion per quarter and the deal pipeline slows, the consensus EPS figures look too high and the multiple looks stretched. That path takes the stock toward the low-$900s before it finds support.

Goldman’s franchise is genuinely stronger than it was five years ago. The AUS engine, the record management fee base, and the structurally dominant prime brokerage position are not going away. But bargain hunters do not buy strong franchises at any price. They buy strong franchises when the price leaves room for the cycle to disappoint. At $1,060, that room is thin.

Hold if you own it. Scale in carefully if you do not. And keep October 13 circled in red.

For informational purposes only. Not investment advice.